Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine With Extended Follow-Up
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
N. Engl. J. Med 2021 Sep 22;[EPub Ahead of Print], HM El Sahly, LR Baden, B Essink, S Doblecki-Lewis, JM Martin, EJ Anderson, TB Campbell, J Clark, LA Jackson, CJ Fichtenbaum, M Zervos, B Rankin, F Eder, G Feldman, C Kennelly, L Han-Conrad, M Levin, KM Neuzil, L Corey, P Gilbert, H Janes, D Follmann, M Marovich, L Polakowski, JR Mascola, JE Ledgerwood, BS Graham, A August, H Clouting, W Deng, S Han, B Leav, D Manzo, R Pajon, F Schödel, JE Tomassini, H Zhou, J MillerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.